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Abstract
Background. Arterial hypertension in children and teenagers is more often perceived as an interdisciplinary prob-
lem. The subject literature most often presents reports concerning medical issues. Very rare are reports presenting 
the problem from the perspective of public health and economy. 
Aim. The aim of the study was to analyse the burden imposed on public health insurance system by providing ser-
vices due to hypertension in children and teenagers in Silesian Province. 
Material and methods. In this paper, the data from the Database of Healthcare Services of the Silesian Regional 
Branch of National Healthcare Fund in 2013 and 2014 and MZ-11 reports were used. 
Results. In Silesian Province, in primary healthcare units in 2013 hypertension was diagnosed in 19,317 patients 
aged 0–18 years, while in 2014 — in 18,173 patients. In 2013 the cost of services provided within specialist outpa-
tient care due to hypertension amounted to 116,853 PLN (for 787 patients), while in 2014 — 130,384 PLN (for 
804 patients). In the years 2013–2014 in clinical centres, 480 hospitalizations for 372 patents with hypertension 
were registered, while in the other hospital healthcare centres — 391. The value of services provided in hospital 
setting was 1,383,923 PLN in 2013 and 1,357,332 PLN in 2014. Essential hypertension (I10 according to ICD) 
in different clinical units was diagnosed in 86.33–88.29% of the hospitalized patients due to hypertension, while in 
other hospitals — in 93.86% of patients with hypertension. 
Conclusion
1. Hospitalizations due to hypertension in patients aged 0–18 years generate the biggest financial burden for the 
payer for services.
2. Nearly half of hospitalizations were provided in academic centres.
3. The most numerous group of the hospitalized individuals were patients at the age of 15–18 who were diagnosed 
with essential hypertension.
4. The scope of services provided during hospitalization in clinical centre departments and regional hospitals signi-
ficantly differs. 
key words: hypertension, children, financing
Arterial Hypertens. 2016, vol. 20, no. 2, pages: 51–59
DOI: 10.5603/AH.2016.0009
arterial hypertension 2016, vol. 20, no. 2
52 www.ah.viamedica.pl
Introduction
Hypertension is more and more frequently perceived 
not only as a medical but also as a social and eco-
nomic problem. According to WHO experts, hyper-
tension is the main cause of death in the world and 
is considered the most widespread disease. In the 
1970s it was claimed that hypertension was mainly 
a disease of adults and therefore routine blood pres-
sure measurements in children were not performed. 
However, the exception was paediatric personnel in 
Johns Hopkins Hospital (Baltimore, USA), who in-
troduced the measurement of blood pressure in chil-
dren into clinical practice already at the beginning of 
the XX century. 
Hypertension in the population of developmen-
tal age is found in 3–5% of children and teenagers 
and is increasing with age [1, 2]. The subject lite-
rature suggests that not only different diagnostic 
criteria were applied but also different methodolo-
gy. Most studies, conducted to assess the frequency 
of hypertension in the developmental age, concern 
schoolchildren. Determining the frequency of hy-
pertension in the population of children and teen-
agers is posing many difficulties resulting mainly 
from the fact that along child’s development the 
values of blood pressure change, which indicates 
a relationship not only to age but also to gender 
and height. Moreover, a very important aspect is 
standardization of measurements which should 
involve, except the proper technique, also the ap-
propriate frequency of performing it. Presently, 
the basis for diagnosing hypertension in children 
is constituted by the values > 95 percentile for 
gender, age, and height observed during three in-
dependent visits [3].
Hypertension in children and teenagers is more 
and more often the subject of studies not only for 
cardiologists and nephrologists but also for teams 
dealing with obesity, endocrinology, diabetology or 
metabolic syndrome. It is assumed that the values of 
hypertension in the early period of life are of crucial 
importance for shaping the values in later periods of 
life. In Poland, in 2006 more than 2.5 million of per-
sons over 18 years of age were registered in primary 
care units with diagnosed hypertension and, what is 
more, the expenditure incurred on treatment during 
that period is estimated at 14 billion PLN a year [4]. 
There are no similar estimations in the population of 
the youngest. 
The range of health care services, including screen-
ing tests, and the period when these studies are con-
ducted in Poland are specified by the regulation of 
Minister of Health [5, 6]. 
Aim of the study
The aim of the study was to assess the burden im-
posed on public health insurance system by provid-
ing services due to hypertension in children in the 
Upper Silesia Province. 
Materials and methods
In this study the information from the Database of 
Healthcare Services of the Silesian Regional Branch 
of National Healthcare Fund about the performance 
of contractual services in 2013 and 2014 was used. 
By using this source of data and reports about the 
activity of the healthcare units (MZ-11) the number 
of the insured individuals at the age of 0–18 years 
for the present year in the Upper Silesian Province 
who, due to hypertension, used primary care services, 
specialist outpatient care and hospital treatment was 
calculated. Next, the volume of funding for treat-
ment of children, who were provided with primary 
care services, specialist outpatient care or hospital 
treatment was assessed. 
Within public health insurance, financing medical 
services concerning hypertension treatment in chil-
dren is performed in the following way: 
Financing by per capita rate in the primary 
healthcare
Primary healthcare is a publicly available part of the 
healthcare system. Primary healthcare doctor may 
refer the patient to diagnostic tests but their range is 
strictly defined (laboratory tests, USG, X-ray). The 
tests from the list of guaranteed medical tests are 
financed within contractual services in the primary 
healthcare units. The primary care unit doctor by 
referring the patient to the specialist or to hospital 
is obliged to perform and attach the diagnostic tests 
results performed to confirm the initial diagnosis. 
If the primary care doctor receives the information 
from the specialist clinic or hospital about the diag-
nosis, treatment method and prescribed medications 
(including the information about ordered medicines 
and dosing), he/she may continue treatment and give 
the patient a prescription for the medicines taking 
into account the rules of drug reimbursement. 
Financing services by assessment of particular 
medical advice in specialist clinics
Outpatient specialist services, which are given in 
specialist clinics, cover three main types of medical 
advice: post-hospitalized, comprehensive and specia-
list, which the payer differentiated in terms of assess-
ment. In order to gain post-hospitalized advice the 
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patient who was hospitalized may, within thirty days 
counted from the hospital stay, go to the doctor from 
the team that was treating the patient during hospi-
talization. Specialist comprehensive advice is a service 
designed for patients who contact the specialist for 
the first time with a specified medical problem. In its 
course the diagnosis is made and further treatment 
is decided. If the patient uses specialist’s advice again 
due to the earlier diagnosed disorder, the service is 
provided within the specialist advice.
Financing hospitalization at rates for  
diagnosis-related groups of patients
A patient can be referred to hospital treatment if the 
goal of treatment cannot be achieved in the outpa-
tient mode. 
According to the definition specified in the Reg-
ulation of Minister of Health, hospitalization is 
a scheduled or urgent 24-hour provision of guaran-
teed services covering the diagnostic and therapeutic 
process from the moment of benefit recipient’s ad-
mission to the moment of his/her discharge or death. 
It covers the costs of performing the necessary lab-
oratory tests, medical imaging, medicinal products 
and medical devices applied during the provision of 
the service [7]. 
Hospital stay as well as diagnostics and therapy of 
hypertension are financed according to the catalogue 
of services. After finishing hospitalization, the patient 
should obtain information sheet and, depending on 
the needs, prescriptions, medical leave and referral to 
further treatment. People under 18 years of age have 
a right for healthcare regardless of the fact whether 
they are insured or not. Financing the services with-
in the public health insurance system does not take 
into account the division of the diagnostic process 
of hypertension. From the perspective of the pay-
er, which is National Healthcare Fund, it precludes 
from compiling a separate calculation of direct and 
indirect costs. 
The services performed in two multi-profile clini-
cal hospitals with full diagnostic facilities were anal-
ysed due to the assumption that an important source 
of information depicting the expenditure incurred 
during hospitalization of children with hypertension 
may be medicinal units possessing properly special-
ized units and comprehensive diagnostic facilities. 
The analysis was limited to the department of paedia-
tric cardiology and nephrology as well as paediatrics 
due to the fact that on different departments children 
with diagnosed hypertension were hospitalized only 
in a few cases. In order to determine the degree 
of involvement of these centres in the process of 
treatment and financing the services, the subject for 
analysis was constituted by other hospitals in Silesian 
Province, which have paediatric departments and in 
which children with hypertension were hospitalized. 
The assessment did not cover the cost of medicines 
due to the lack of possibility of conducting the ana-
lysis in this area. 
Results
In 2013 in primary care units of the Silesian Prov-
ince 19,317 patients at the age of 0–18 with diag-
nosed hypertension were registered, while in 2014 
the number was 18,173. Taking into account the 
method of financing the services in primary care 
units (annual per capita rate) it is not possible to 
assess simultaneously the expenditure incurred by the 
payer on diagnosing and treatment of patients with 
a specified disease. 
Within specialist outpatient treatment, due to hy-
pertension in the age group of 0–18 in 2013, 787 
patients were given medical advice, while in 2014 the 
number equalled 804 (Table I).
In 2013–2014, in the selected clinical centres the 
total number of hospitalizations on paediatric car-
diology and nephrology departments and paediatrics 
was 480 for 372 patients with hypertension (accord-
ing to ICD-10; I10-I15). In this group 88% of hos-
pitalizations were connected with the disease entity 
I10 — essential (primary) hypertension. The data 
analysis, concerning hospitalization of children diag-
nosed with hypertension proves that in the cardiolog-
ical department the essential hypertension amount-
ed to 86%, while in the department of paediatric 
nephro logy — 88%. In paediatric department where 
8 patients with hypertension were hospitalized, 7 of 
them were diagnosed with essential hypertension. 
The percentage proportion of hospitalization with 
Table I. Total value of services in 2013–2014 including the type
Type of services The value of services in 2013 The value of services in 2014
Primary care unit Annual per capita rate Annual per capita rate
Specialist Outpatient Clinic 116,853 PLN 130,394 PLN
Hospital treatment 1,382,923 PLN 1,357,332 PLN
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Table II. The percentage proportion of diagnoses I10-I15 (according to ICD-10) in patients hospitalized in clinical departments in 2013–2014
Scope  
of services
Code of 
diagnosis
Name of diagnosis Number  
of hospitalizations 
Percentage 
share
Paediatric  
cardiology
I10 Essential (primary) hypertension 120 86.33%
I11.9 Hypertensive heart disease without (congestive) heart failure 1 0.72%
I15.1 Secondary hypertension to other renal disorders 1 0.72%
I15.8 Other secondary hypertension 15 10.79%
I15.9 Secondary hypertension, unspecified 2 1.44%
Paediatric  
nephrology
I10 Essential (primary) hypertension 294 88.29%
I15.0 Renovascular hypertension 5 1.50%
I15.1 Secondary hypertension to other renal disorders 23 6.91%
I15.8 Other secondary hypertension 5 1.50%
I15.9 Secondary hypertension, unspecified 6 1.80%
Paediatrics I10 Essential (primary) hypertension 7 87.50%
I15.9 Secondary hypertension, unspecified 1 12.50%
Table III. The percentage proportion of diagnoses I10-I15 (according to ICD-10) in patients hospitalized in paediatric departments in other 
hospitals of Silesian Province in 2013–2014
Scope  
of services
Code of 
diagnosis
Name of diagnosis Number of 
hospitalizations 
Percentage 
share
Paediatrics I10 Essential (primary) hypertension 367 93.86%
I12.9 Hypertensive renal disease without renal failure 1 0.26%
I15.0 Renovascular hypertension 2 0.51%
I15.1 Secondary hypertension to other renal disorders 1 0.26%
I15.8 Other secondary hypertension 3 0.77%
I15.9 Secondary hypertension, unspecified 17 4.35%
type of diagnosis and the profile of the department is 
presented in Table II. 
Table III presents the information about treatment 
of patients in other hospitals of Silesian Province 
which have paediatric departments in their structure.
In 2013–2014 in the other 28 hospitals, the total 
number of hospitalizations in paediatric departments 
was 391 for 375 patients. 
Similarly to clinical centres, the dominating disease 
entity was essential (primary) hypertension (I10).
Based on the above-mentioned facts, it can be 
concluded that children and teenagers with hyper-
tension were hospitalized in specialized academic 
centres, mainly in paediatric cardiology and nephro-
logy departments, while in other hospitals in paedia-
tric departments. 
The Table IV shows the number of services in 
cardiology and nephrology department including the 
type of diagnosis in age groups: up to 10 years of age, 
up to 11, up to 14 and up to 15 and 18 years of age. 
The average time of hospitalization in cardiology 
department amounted to 5.2 days, nephrology 2.8 
days, while in paediatric department 5.8 days. 
From the reports sent to the Database of Health-
care Services of the National Healthcare Fund in 
Katowice (according to the current ICD-9) it can 
be concluded that during hospitalization in the 
paediatric cardiology department in all children 
diagnostic the following medical procedures were 
performed: 
 — anthropometric measurements; 
 — ECG; 
 — ECG monitoring; 
 — echocardiography; 
 — blood pressure monitoring; 
 — Holter RR blood pressure monitoring; 
 — USG-Doppler in particular areas; 
 — cardiovascular stress test (almost in 100%).
Furthermore, in over 50% of hospitalizations, 
ophthalmoscopy and chest X-ray were performed. 
Teresa Bilewicz-Wyrozumska et al. Financing medical services in children with arterial hypertension
55www.ah.viamedica.pl
Table IV. The number of hospitalizations in 2013–2014 in clinical department of cardiology, nephrology and paediatrics divided into age 
and diagnosis according to ICD-10
Scope  
of services 
Code  
of diagnosis
Name  
of diagnosis
Age up to 10 Age from 11 
to 14
Age from 15 
to 18
Paediatric 
cardiology
I10 Essential (primary) hypertension 4 24 92
I11.9 Hypertensive heart disease without (congestive) 
heart failure
— — 1
I15.1 Secondary hypertension to other renal disorders — — 1
I15.8 Other secondary hypertension 3 5 7
I15.9 Secondary hypertension, unspecified 1 1 —
Paediatric 
nephrology
I10 Essential (primary) hypertension 32 62 200
I15.0 Renovascular hypertension 1 1 3
I15.1 Secondary hypertension to other renal disorders 9 5 9
I15.8 Other secondary hypertension 3 — 2
I15.9 Secondary hypertension, unspecified 2 2 2
Paediatrics I10 Essential (primary) hypertension — 2 5
I15.9 Secondary hypertension, unspecified — — 1
Table IVA. The number of hospitalizations in 2013–2014 in paediatric departments divided into age and diagnosis according to ICD-10 in 
the other centres 
Scope  
of services 
Code  
of diagnosis
Name of diagnosis Age up to 10 Age from 11 
to 14
Age from 15 
to 18
Paediatrics I10 Essential (primary) hypertension 18 85 263
I12.9 Hypertensive heart disease without (congestive) heart failure — — 1
I15.0 Renovascular hypertension 1 — 1
I15.1 Secondary hypertension to other renal disorders 1 — —
I15.8 Other secondary hypertension — 1 2
I15.9 Secondary hypertension, unspecified 2 2 13
In the nephrology department it was found that 
during hospitalization the following tests were per-
formed repeatedly: 
— anthropometric measurements; 
— monitoring blood pressure; 
— urinanalysis; 
— USG of particular abdominal areas; 
— USG Doppler. 
Monitoring blood pressure with Holter RR was 
performed in over 50%, while computed tomogra-
phy only incidentally. 
In paediatric departments of the other hospitals 
in Silesian Province, in the majority of hospitalized 
children ECG, monitoring blood pressure, echocar-
diography, abdominal and retroperitoneal ultraso-
nography were performed, while in 30% of children 
USG-Doppler in renal and urinary tract areas and 
USG of thyroid and parathyroids were done. The 
most often performed tests within laboratory diag-
nostics were general urinanalysis, concentration of 
creatinine, uric acid, lipid profile and thyroid hor-
mones. Occasionally hospitals were reporting such 
services to the National Healthcare Fund System as: 
computed tomography, magnetic resonance, urogra-
phy and angiography. The information about anthro-
pometric measurements and monitoring with Holter 
was not reported. 
Taking into consideration the fact that financ-
ing hospitalization by public payer, which is Na-
tional Healthcare Fund, it should be emphasized 
that it covers the comprehensive patient care ac-
cording to the current definition. The expenditure 
incurred on providing services results from the rate 
for diagnosis-related groups. In 2013–2014 they 
amounted totally to 2,740,255 PLN including 
1,661,900 PLN in clinical centres. 
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Table V. The value of services performed in 2013–2014 in clinical department of cardiology, nephrology and paediatrics divided into age 
and diagnosis according to ICD-10
Scope  
of services
Code  
of diagnosis
Name of diagnosis Age up to 10 Age from 11 
to 14
Age from 15 to 18
Paediatric  
cardiology
I10 Essential (primary) hypertension 11,856 PLN 71,136 PLN 275,548 PLN
I11.9 Hypertensive heart disease without (congestive) 
heart failure
— — 2,964 PLN
I15.1 Secondary hypertension to other renal disorders — — 2,964 PLN
I15.8 Other secondary hypertension 11,752 PLN 14,820 PLN 20,748 PLN
I15.9 Secondary hypertension, unspecified 4,212 PLN 3,900 PLN
Paediatric  
nephrology
I10 Essential (primary) hypertension 78,772 PLN 166,249 PLN 507,443 PLN
I15.0 Renovascular hypertension 2,756 PLN 2,756 PLN 11,076 PLN
I15.1 Secondary hypertension to other renal disorders 24,799 PLN 13,754 PLN 24,751 PLN
I15.8 Other secondary hypertension 8,268 PLN — 5,512 PLN
I15.9 Secondary hypertension, unspecified 3,296 PLN 5,486 PLN 5,486 PLN
Paediatrics I10 Essential (primary) hypertension — 5,512 PLN 13,780 PLN
I15.9 Secondary hypertension, unspecified — — 2,756 PLN
Table VA. The value of services divided into age and diagnosis (according to ICD-10) performed in 2013–2014 in paediatric departments in 
the other hospitals
Scope  
of services
Code  
of diagnosis
Name of diagnosis Age up to 10 Age from 11 
to 14
Age from 15 
to 18
Paediatrics I10 Essential (primary) 
hypertension
49,861 PLN 227,284 PLN 714,208 PLN
I12.9 Hypertensive heart disease without (congestive) 
heart failure
— — 3,172 PLN
I15.0 Renovascular hypertension 2,756 PLN — 572 PLN
I15.1 Secondary hypertension to other renal disorders 2,756 PLN — —
I15.8 Other secondary 
hypertension
— 2,756 PLN 5,512 PLN
I15.9 Secondary hypertension, unspecified 6,090 PLN 5,512 PLN 35,828 PLN
In the case of hospitalization of a child with hyper-
tension in paediatric cardiology department, the basic 
accounting group was E79 (other circulatory system 
disorders) at a basic price equalling 2,964 PLN. How-
ever, for paediatric nephrology department the account-
ing group was defined as P21 (heart diseases) with a ba-
sic price for hospitalization amounting to 2,756 PLN. 
The difference in financing the same disease entities 
between hospital departments amounted to 208 PLN. 
In the other hospitals in paediatric departments 
in the corresponding period financing hospitaliza-
tion amounted to 1,078,355 PLN, which represents 
39.35% of the total amount devoted to patient hos-
pitalization with hypertension in the age group from 
0–18 years of life, while the most frequently declared 
diagnosis-related group was, similarly to paediatric 
nephrology, the group P21 (heart diseases). 
Total expenditure incurred by National Healthcare 
Fund on hypertension treatment according to ICD-10 
diagnoses in relation to the age group of patients was 
calculated after recounting the unit value of hospi-
talization in the entity in question by the number of 
provided services, which is presented in Table V. 
Due to the lack of generally applicable detailed 
assessment of medical procedures, it is difficult to 
refer to the cost of hypertension diagnostics in chil-
dren in a detailed analysis. In many well-known units 
detailed costs of different tests have been developed, 
but they are treated as confidential data and are not 
generally available. However, the prices of commer-
cial services are available on the Internet. 
Table VI presents exemplary prices of commercial 
procedures performed in medicinal units in relation 
to three stages of diagnostics.
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Table VI. Commercial prices of procedures at different stages of hypertension diagnostics
3 stages of diagnostic procedure
Type of test
John Paul II 
Upper Silesian 
Child Health 
Centre
University 
Children’s 
Hospital 
of Cracow
Independent 
Public Children’s 
Clinical Hospital 
in Warsaw
University  
of Bialystok  
Children‘s  
Clinical Hospital
STAGE 1
Collecting material 3.69 PLN — 11.00 PLN 10.00 PLN 
CBC 9.84 PLN 12.00 PLN 12.00 PLN 11.00 PLN 
Creatinine 6.77 PLN 6.00 PLN 12.00 PLN 5.50 PLN 
Sodium 6.77 PLN 6.00 PLN 10.00 PLN 6.00 PLN 
Potassium 6.77 PLN 6.00 PLN 10.00 PLN 6.00 PLN 
Chloride 6.77 PLN 6.00 PLN 14.00 PLN 5.50 PLN 
Calcium 6.77 PLN 6.00 PLN 10.00 PLN 6.00 PLN 
Bicarbonates 18,45 PLN — 14,00 PLN —
Total cholesterol 6.77 PLN 6.00 PLN 12.00 PLN 6.00 PLN 
HDL fraction 12.30 PLN 8.00 PLN 12.00 PLN 7.50 PLN 
LDL fraction 12.30 PLN 10.00 PLN 29.00 PLN 17.00 PLN 
Triglycerides 13.53 PLN 7.00 PLN 12.00 PLN 6.00 PLN 
Uric acid 7.38 PLN 6.00 PLN 12.00 PLN 6.00 PLN 
Glucose 6.77 PLN 6.00 PLN 12.00 PLN 5.50 PLN 
Urinalysis 9.23 PLN 4.00 PLN 18.00 PLN 7.50 PLN 
 24 hour albuminuria or index 43.05 PLN 22.00 PLN 28.00 PLN —
Albumin/creatinine in urine 12.30 PLN 6.00 PLN 28.00 PLN 10.50 PLN 
Ophthalmoscopy — 100.00 PLN — —
Kidney and renal arteries USG-Doppler — — 180.00 PLN 110.00 PLN 
Left ventricular mass and aortic arch echocardiographic  
assessment 
— — 130.00 PLN —
IMT assessment 100.00 PLN — 120.00 PLN —
Cranial Ultrasonic Scans in newborns — 100.00 PLN 100.00 PLN —
ABPM in children > 5 years of life HOLTER — — 120.00 PLN —
STAGE II
 Glycaemia, oral glucose tolerance test, insulinaemia in patients 
with BMI>85. cc 
6.77 PLN — — —
Catecholamine release assessment in younger children and all 
patients with 2 degree hypertension
— 160.00 PLN — —
Serum renin activity/renin and aldosterone concentration in 
younger children and all patients with 2 degree hypertension
— 45.00 PLN — —
Urine steroid profile or 17 keto- and hydroxysteroid assay in 
younger children and all patients with 2 degree hypertension
— 50.00 PLN — —
TSH 24.60 PLN 23.00 PLN 18.00 PLN 13.50 PLN 
FT3 24.60 PLN 23.00 PLN 18.00 PLN 15.00 PLN 
FT4 24.60 PLN 23.00 PLN 18.00 PLN 14.50 PLN 
Vitamin D3 metabolites — 100.00 PLN 48.00 PLN 43.50 PLN 
Renal scintigraphy (captipril test) in younger children and all 
patients with 2 degree hypertension
— 560.00 PLN — —
STAGE III
Non-invasive and invasive medical imaging of renal arteries — — — —
Angio-CT 550.00 PLN 500.00 PLN — 460.00 PLN 
Angio-MR — — — 500.00 PLN 
Classic arteriography — — — —
Medical imaging of adrenal and paraganglioma pathology — — — —
Non-invasive vascular angiography of other vascular areas (ce-
liac artery, intracranial arteries) 
— — Doppler 180.00 
PLN 
—
Molecular test — 407.00– 
–1,200.00 PLN* 
Cytogenetic 
570.00 PLN 
—
*typical molecular test 
Source: Websites of the above-mentioned hospitals
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Discussion
There are few reports about calculation of costs 
linked to hypertension in Poland and almost all of 
them concern adults or young adults. Reports refer-
ring to Polish population of the developmental age 
are rare [8]. 
The diagnostic process is multi-stage and should 
take into consideration the exclusion of secondary 
causes of hypertension. The Polish Society of Hy-
pertension in the 2015 guidelines for the manage-
ment of hypertension specifies in detail the stages 
of diagnostics and different procedures assigned to 
them [3]. According to experts, echocardiography 
and microalbuminuria test should be performed in 
every child with hypertension [9]. In this area, the 
role of General Practitioner is limited by the list of 
guaranteed services in primary healthcare units. The 
doctor may order a general urinalysis, but in the 
case of echocardiography he/she must refer a pa-
tient to a cardiology clinic. If organ changes are 
found, it is advisable to intensify the diagnostic and 
therapeutic process. 
As it results from National Healthcare Fund re-
port published in 2010, 14% of the whole refund 
budget was used on the pharmacotherapy of car-
diovascular disorders. The calculation of indirect 
and direct costs may provide information about the 
financial effects linked to hypertension treatment. 
In the Polish subject literature, this information is 
available but concerns only the population of adults. 
In 2011 the total cost of diagnostics and treatment 
of hypertension in hospitals amounted to 3,303.42 
PLN. The analysis concerned 110 patients at the 
age of > 50, but the calculations did not take into 
account salaries of personnel and depreciation of 
equipment. The total expenditure connected with 
hospitalization was mainly generated by disorders 
accompanying hypertension often occurring at this 
age. In overall costs of diagnostics, the cost of test 
for patients with isolated hypertension equalled 1%. 
It was assessed that the functioning costs of the de-
partment constituted about 30% of indirect medical 
costs [11]. In the other study (PENT) the authors 
conducted a calculation for patients over 18 years 
participating in the epidemiological program assess-
ing the frequency of hypertension in Poland and 
found that the direct costs constituted 10.3 billion 
PLN, while indirect costs amounted to about 2.7 
billion (73.6% and 26.4% respectively). Direct costs 
included: medical advice which constituted 31%, 
hospitalization — 21%, specialist and diagnostic 
tests — 11% and expenditures on medicine — 10% 
[12]. In DETENT study performed in 2008 it was 
found that cardiologists more often apply new gene-
ration of medicines rather than the primary care 
doctors [13].
On the basis of the analysis of the material con-
cerning diagnostics and treatment of children with 
hypertension in the Silesian Province, it may be con-
cluded that the biggest financial burden for National 
Healthcare Fund was constituted by services linked 
to patients’ hospitalization. The most numerous 
group consisted of patients at the age between 15 
and 18 years who were eventually diagnosed with 
essential (primary) hypertension (I10). This trend 
persists despite the differences resulting from the 
profile of specialization. 
Taking into consideration the aim of the study 
and applied methodology, this study cannot be in-
terpreted in the category of an epidemiological study. 
The obtained results in the area of hypertension in 
children and teenagers rather indicate the need of 
conducting an epidemiological study and related ad-
vanced economic analyses. There are a few reasons 
that determine the limitations in interpretation of the 
results. In the present reporting system concerning 
financing of services by National Healthcare Fund, 
detailed determination of the structures of health 
problems in primary healthcare unit is not possible 
because such data are not registered. To a certain limi - 
ted extent some data may be gained from MZ-11 re-
ports conveyed to the Centre of Health Information 
System. The authors of the report used this source to 
determine the number of children and teenagers with 
hypertension covered by active care of primary care 
unit doctors. The obligation of conveying statistical 
data is due to the regulation about public statistics, 
while the responsibility for preparing a correct re-
port lies with the Head of the unit [14]. The basis 
for filling in the form is medical documentation 
which must be maintained by all healthcare units. 
Under the current regulations, by diagnosing hy-
pertension in a child the doctor (after 3 subsequent 
visits during which he/she founds the value of blood 
pressure equal or over 95 percentile for gender, age 
and height) should commence diagnostics in order to 
determine the type of hypertension. However, during 
every visit, according to the Regulation of Minister 
of Health the doctor is obliged to make a diagnosis 
even if the patient is still under observation [15]. 
Another question concerning properly registered 
(and reported) diagnoses appears at the moment of 
choosing the code according to the commonly used 
system ICD-10, when the doctor may choose one 
of the types of hypertension from I10 do I15. At an 
early stage of diagnostics, the solution would be to 
choose R03 code (elevated blood pressure without 
Teresa Bilewicz-Wyrozumska et al. Financing medical services in children with arterial hypertension
59www.ah.viamedica.pl
hypertension). The category should be applied to 
indicate an elevated blood pressure in the patients, 
who cannot be diagnosed with hypertension due to 
the lack of basis, or a one-time casual blood pressure 
measurement during the initial observation of the 
patient. As it results from controls of medical docu-
mentations, such actions were not common. 
In the analysed material, the differences in the 
range of applied diagnostic procedures between de-
partments of clinical centres and other paediatric 
departments were noted. The diagnostic process of 
hypertension in children and teenagers conducted in 
cardiology departments was most compatible with the 
current guidelines of Polish Society of Hypertension. 
Conclusions
According to prognoses, in the nearest future 588 
million more people are expected to be diagnosed 
with hypertension, while the total number of pa-
tients in the world will amount to 1.56 billion [16]. 
It may be assumed that the number of ill individuals 
in Poland will also increase and therefore the expen-
diture on treatment will grow as well. The prognosis 
concerning the population of developmental age are 
not known. The analysis of financing services linked 
to hypertension may provide much valuable infor-
mation also in the area of medical policy and public 
health design. The detailed assessment of diagnostic 
and therapeutic procedures applied in children with 
hypertension as well as clarification of qualification 
rules of diagnoses according to the system ICD-10 
would increase the value of the source material pos-
sessed by National Healthcare Fund. Development 
and dissemination of code systems (QR codes, Tags, 
RFID) and reading (scanners/code and tags read-
ers) during performing the procedures in diagnostic 
and medicinal units would significantly facilitate 
documenting them (the type, number etc.) as well 
as relieve the medical personnel. From the per-
spective of disease management it seems that it 
would also be easier to take administrative decision 
concerning centralization and decentralization of 
diagnostic and medicinal centres for children with 
hypertension. 
Joint studies and analyses by teams consisting of 
clinicians, epidemiologists and National Healthcare 
Fund workers including economists and lawyers 
would enable to present the problem of hyperten-
sion in children from a different perspective, which 
would consequently lead to introduction of benefi-
cial changes in the field of prevention, improvement 
of diagnostic and therapeutic organizational process 
and the efficacy of service financing. 
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